Fred Aslan, MD, CEO, Artiva Biotherapeutics, explains what the FDA Fast Track designation for AlloNK in autoimmune diseases means for the acceleration of its development and potential approval of the ...

The software can determine the extent and severity of coronary plaque build-up implicated in coronary artery disease.

This is just the new way of consuming nicotine,” a vape shop owner in West Campus says of continuing to sell flavored vapes.

Two other people were arrested Monday and also are expected to be arraigned in the child's death, police said.

Magellan Diagnostics’ former CEO Amy Winslow has pleaded guilty to concealing malfunctions in the company’s LeadCare lead ...

Michigan Attorney Dana Nessel said key facility staff "held safety among their lowest considerations in their hyperbaric ...

Doron Therapeutics, a clinical-stage biotechnology company based in Chapel Hill, has received a Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration ...

Two recent documents—one from the FDA, the other from a commission organized by The Lancet Diabetes & Endocrinology—indicate ...

Four Oxford Center employees, including the CEO and safety manager, have been charged in connection to the death of a ...

It’s only February, but my pick for the Worst Biopharma CEO of 2025 has already been decided ... for its all-too-cozy relationship with the FDA, including its penchant for hiring former top ...

The FDA has declared the shortages as “resolved ... demand for the compounded versions of the drug,” Scott Brunner, CEO of Alliance for Pharmacy Compounding, another compounding industry ...

Inspira™ Technologies OXY B.H.N. Ltd. ("Inspira," "Inspira Technologies" or the "Company") (Nasdaq: IINN), a pioneering force in the evolution of respiratory support and real-time blood-monitoring ...